Atrial fibrillation is commonly encountered by the medical consultant, including patients with preexisting atrial fibrillation, as well as those with new onset in the perioperative period. Balancing the risk of stroke versus the risk of bleeding complications is required for the perioperative management of anticoagulation. Additionally, strategies for maintaining rate and/or rhythm control must be considered. Management options are frequently restricted by a patient’s NPO status postoperatively.
KeywordsIschemia Heparin Anemia Stratification Warfarin
- 1.University of Washington Medical Center Anticoagulation Clinic website: uwmcacc.org. Accessed Nov 2011.
- 3.Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic therapy and prevention of thrombosis, 9th edition: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2) (Suppl):e326s–e350s.PubMedCrossRefGoogle Scholar
- 4.Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation—executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. Circulation. 2006;114(7):e257–354.PubMedCrossRefGoogle Scholar